Jin et al [15] reported data on 141 surgically resected stage I adenocarcinomas; they found that higher MET gene copy number is associated with worse overall survival (p = 0.01) and progression free survival (p<0.001), nevertheless there was no HR reported. Here, MET is linked to adenocarcinoma.